风湿性关节炎是否会增加COPD的风险? :一个全国性的回顾性队列研究
Chiwook Chung1, Hyungjin Kim2, Kyungdo Han3
1Department of Pulmonary and Critical Care Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung.
Chest
|February 16, 2024
概括
类风湿性关节炎 (RA) 显著增加患慢性阻塞性肺病 (COPD) 的风险. 血清阳性RA比血清阴性RA具有更高的COPD风险,突出了RA患者呼吸系统监测的必要性.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 类风湿性关节炎 (RA) 是一种全身性炎症性疾病,已知肺部表现,主要是间歇性肺部疾病.
- RA 和慢性阻塞性肺病 (COPD) 都是慢性炎症状况,表明潜在的共享途径或增加风险.
研究的目的:
- 调查类风湿性关节炎 (RA) 是否增加患慢性阻塞性肺病 (COPD) 的风险.
- 为了确定是否存在血清阳性和血清阴性RA患者之间COPD风险的差异.
主要方法:
- 一项基于人口的队列研究,使用韩国国家医疗保险数据库.
- 鉴定了46,030名RA患者 (血清阳性和血清阴性) 和230,150名对照,从2010年到2019年进行监测.
- 多变量Cox比例危险模型被用于计算COPD发展的调整危险比率 (aHR).
主要成果:
- 与对照组相比,RA患者患上COPD的风险增加了2.11倍 (aHR,2.11;95% CI,1.96-2.28).
- 血清阳性和血清阴性RA都增加了COPD风险,而血清阳性RA显示出更高的风险 (aHR,1.26;95% CI,1.09至1.46).
- 吸烟史在COPD发展中与RA没有显著的相互作用.
结论:
- 类风湿性关节炎与COPD发展的风险增加有关.
- 血清阳性进一步增加了 RA 患者的 COPD 风险.
- 临床医生应密切监测RA患者的呼吸系统症状和肺功能.
相关概念视频
COPD: Pathogenesis and Clinical Features
273
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
273
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206


